Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) is 75.57% higher on its value in year-to-date trading and has touched a low of $8.06 and a high of $18.05 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The TEVA stock was last observed hovering at around $18.01 in the last trading session, with the day’s gains setting it 0.32%.
Currently trading at $18.33, the stock is 7.92% and 8.81% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 8.98 million and changing 1.78% at the moment leaves the stock 35.79% off its SMA200. TEVA registered 92.34% gain for a year compared to 6-month gain of 39.18%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 11.90% loss in the last 1 month and extending the period to 3 months gives it a 9.24%, and is 6.82% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.87% over the week and 3.45% over the month.
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) has around 37226 employees, a market worth around $20.77B and $16.30B in sales. Fwd P/E is 6.58. Profit margin for the company is -2.72%. Distance from 52-week low is 127.56% and 1.55% from its 52-week high. The company has generated returns on investments over the last 12 months (-1.91%).
Teva- Pharmaceutical Industries Ltd. ADR quarterly earnings per share for the current quarter are estimated at 0.66 with sales reaching $4.11B over the same period.The EPS is expected to shrink by -4.02% this year, but quarterly earnings will post 2.40% year-over-year. Quarterly sales are estimated to grow 6.80% in year-over-year returns.
719.0 institutions hold shares in Teva- Pharmaceutical Industries Ltd. ADR (TEVA), with institutional investors hold 55.43% of the company’s shares. The shares outstanding are 1.13B, and float is at 1.13B with Short Float at 1.72%. Institutions hold 55.43% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 43.7 million shares valued at $$616.67 million. The investor’s holdings represent 3.8918 of the TEVA Shares outstanding. As of 2024-03-31, the second largest holder is ION ASSET MANAGEMENT LTD. with 38.58 million shares valued at $$544.34 million to account for 3.4353 of the shares outstanding. The other top investors are PHOENIX HOLDINGS LTD. which holds 34.58 million shares representing 3.0794 and valued at over $$488.08 million, while MIGDAL INSURANCE & FINANCIAL HOLDINGS LTD. holds 2.6588 of the shares totaling 29.86 million with a market value of $$421.29 million.
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Insider Activity
The most recent transaction is an insider sale by Daniell Richard, the company’s Exec. VP, European Commercial. SEC filings show that Daniell Richard sold 98,943 shares of the company’s common stock on Aug 12 ’24 at a price of $17.30 per share for a total of $1.71 million. Following the sale, the insider now owns 0.0 shares.
Teva- Pharmaceutical Industries Ltd. ADR disclosed in a document filed with the SEC on Aug 09 ’24 that Grant Angus (EVP, Business Development) sold a total of 4,065 shares of the company’s common stock. The trade occurred on Aug 09 ’24 and was made at $17.28 per share for $70243.0. Following the transaction, the insider now directly holds 8848.0 shares of the TEVA stock.
Still, SEC filings show that on Aug 09 ’24, Hughes Eric A (See “Remarks”) disposed off 45,060 shares at an average price of $17.38 for $0.78 million. The insider now directly holds 0 shares of Teva- Pharmaceutical Industries Ltd. ADR (TEVA).
